Skip to main content
NoticePayment processing is currently down, so we are not taking new orders right now. Thank you for your patience.
For laboratory research use only. Not for human or veterinary use.
Free UPS Ground on 3+ vials · same business day by 2 PM ET
LongevityCompanion animal

Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design

Ross JL, Bilkei-Gorzo A, Brzezicka A, et al. · GeroScience · 2023
PMID: 37261678 · DOI: 10.1007/s11357-023-00830-5
Summary

Preclinical nonhuman primate trial of long-term intermittent dasatinib + quercetin senolytic regimen. Endpoints: senescence markers, systemic inflammation, functional aging outcomes over the dosing window.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

More Longevity citations
Browse the catalog